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Long-Term Hematopoietic Stem Cells
Require Stromal Cell-Derived Factor-1
for Colonizing Bone Marrow during Ontogeny
(41 integrin), 1 integrin, VCAM-1, or CD44 prevented
homing of hematopoietic progenitors to adult bone mar-
row and spleen (Papayannopoulou et al., 1995; Vermeu-
len et al., 1998; Williams et al., 1991). However, genetic
deletion of VCAM-1 or CD44 gene did not affect hemato-
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poiesis in bone marrow and spleen (Friedrich et al., 1996;Kyoto University
Schmits et al., 1997) and 4 integrin-deficient multipo-53 Kawahara-cho, Shogoin, Sakyo-ku
tent progenitors developed normally in fetal liver, boneKyoto 606-8507
marrow, and spleen (Arroyo et al., 1996, 1999), suggestingJapan
that these molecules are dispensable for homing of2 Department of Immunology
HSCs. In contrast, it has been shown that 1 integrin-Research Institute
deficient hematopoietic cells were unable to seed fetalOsaka Medical Center for Maternal and Child Health
liver, bone marrow, spleen, and thymus, indicating that840 Murodo-cho, Izumi
1 integrins are critical for the colonization of all fetalOsaka 594-1101
and adult hematopoietic organs (Hirsch et al., 1996; Po-Japan
tocnik et al., 2000). Selectins have been shown to be
essential for leukocyte homing to peripheral lymph
nodes in health and disease. In mice deficient in bothSummary
P- and E-selectins, bone marrow myelopoiesis was in-
creased but homing of hematopoietic progenitors intoThe physiological role of SDF-1 on hematopoietic stem
bone marrow after irradiation was impaired (Frenette etcells (HSCs) remains elusive. We show that coloniza-
al., 1996, 1998). Thus their physiological roles in hemato-tion of bone marrow by HSCs in addition to myeloid
poietic colonization events remain unclear.cells is severely impaired in SDF-1/ embryos by a
Among a variety of hematopoietic cytokines, only thelong-term repopulation assay. Colonization of spleen
chemokine, stromal cell-derived factor-1/pre-B-cellby HSCs was also affected, but to a lesser extent.
growth-stimulating factor (SDF-1/PBSF), has been shownEnforced expression of SDF-1 under the control of
to be involved in hematopoietic colonization during em-vascular-specific Tie-2 regulatory sequences could
bryogenesis (Nagasawa et al., 1996a; Nagasawa, 2000).completely rescue the reduction of HSCs but not my-
Chemokines are a large family of structurally relatedeloid cells in SDF-1/ bone marrow. SDF-1 was de-
chemoattractive cytokines, which act via hepta helicaltected in the vicinity of the vascular endothelial cells
receptors coupled to heterotrimeric GTP binding pro-in fetal bone marrow. SDF-1 plays a critical role in
teins (Baggiolini et al., 1997). SDF-1 was isolated fromcolonization of bone marrow by HSCs and myeloid
bone marrow stromal cell lines and first characterizedcells during ontogeny, and the mechanisms by which
as a pre-B cell growth-stimulating factor (Nagasawa etSDF-1 functions are distinct between HSCs and my-
al., 1994, 1999). CXCR4 has been shown to be a primaryeloid cells.
physiologic receptor for SDF-1 (Bleul et al., 1996; Ma et
al., 1998; Nagasawa et al., 1996a, 1996b; Oberlin et al.,Introduction
1996; Tachibana et al., 1998; Zou et al., 1998) and also
function as an entry coreceptor for strains of HIV-1 (FengHematopoietic stem cells (HSCs) are defined as cells
et al., 1996; Nagasawa et al., 1998). The multiple essen-
with the ability to supply all the various types of blood
tial functions of SDF-1 and CXCR4 in development have
cells throughout life (Weissman, 2000). HSCs are mobile
been demonstrated using mutant mice with targeted
and sequence of hematopoietic colonization events oc- gene disruption (Nagasawa et al., 1996a; Tachibana et
curs during ontogeny. It has been assumed previously al., 1998; Zou et al., 1998). SDF-1 and CXCR4 are essen-
that the first HSCs are generated in the AGM (aorta, tial for B cell development, blood vessel formation in
gonad, and mesonephros) region and move to the fetal gastrointestinal tract, cardiac ventricular septum forma-
liver, the principal hematopoietic organ during em- tion, cerebellar development, and embryonic viability
bryogenesis (Cumano et al., 1996; Medvinsky and Dzier- (Ma et al., 1998; Nagasawa et al., 1996a; Tachibana et
zak, 1996). Later, HSCs migrate to colonize the spleen al., 1998; Zou et al., 1998). In B cell development, it has
and bone marrow, which is the primary hematopoietic been shown that dependency on SDF-1 appears at the
site throughout adult life. In this process, HSCs may earliest stages in both fetal liver and bone marrow
transmigrate across the endothelium to reach a putative (Egawa et al., 2001). Of particular note, SDF-1/ or
hematopoietic stem cell niche in bone marrow or spleen. CXCR4/ embryos have much more impaired myelo-
These colonizations of hematopoietic organs by HSCs poiesis in bone marrow compared with myelopoiesis in
are systematic and believed to be controlled by adhe- fetal liver, suggesting that SDF-1 and CXCR4 are in-
sion receptors and cytokines. The experiments using volved in colonization of bone marrow by hematopoietic
neutralizing antibodies suggested the importance of ad- progenitors during embryogenesis (Ma et al., 1998; Na-
hesion receptors. Treatment of antibodies against VLA-4 gasawa et al., 1996a; Tachibana et al., 1998; Zou et
al., 1998). However, considering that erythropoiesis was
less affected in CXCR4/ embryonic marrow (Zou et3 Correspondence: tnagasa@frontier.kyoto-u.ac.jp
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al., 1998), there is the possibility that HSCs are not af- et al., 1996a). We analyzed hematopoiesis including
erythropoiesis in fetal bone marrow from control or SDF-fected but instead homing or expansion of myeloid and
1/ embryos by flow cytometry, using the B lymphoidB lymphocyte precursors is impaired in SDF-1/ or
markers B220 and CD19 and myeloid marker Gr-1 andCXCR4/ bone marrow. It has been shown that human
erythroid marker Ter119. In E18.5 SDF-1/ bone mar-CD34 hematopoietic progenitor cells from bone mar-
row, the numbers of Gr-1 and B220CD19 cells wererow or fetal blood migrate in response to SDF-1 in vitro
severely reduced but the numbers of Ter119 cells wereand that plasma elevation of SDF-1 induces increase
normal or modestly reduced compared to control em-in murine hematopoietic progenitors in the peripheral
bryos (Figure 1A). These results raise the possibility thatblood, supporting a role for SDF-1 in mobilization of
the mutation in SDF-1 does not affect HSCs that gener-primitive hematopoietic progenitors (Aiuti et al., 1997;
ate all hematopoietic lineage cells including erythroidHattori et al., 2001; Kim and Broxmeyer, 1998; Peled et
cells but instead affects myeloid or B lymphoid precur-al., 1999a; Sweeney et al., 2002). Experiments using
sors in fetal bone marrow. Thus we were prompted toradiation chimeras with lethally irradiated adult mice
examine directly the colonization of bone marrow byrevealed a modest reduction in long-term myeloid re-
HSCs in SDF-1/ embryos. HSCs are capable of long-constitution by CXCR4/ fetal liver cells (Kawabata et
term multilineage reconstitution of adults. The only com-al., 1999; Ma et al., 1999). In addition, it has been shown
pletely unambiguous measure of HSCs is long-termthat treatment of immature human bone marrow CD34
transplantation. Thus, we estimated the numbers ofcells with anti-CXCR4 antibodies prevents short-term
HSCs using repopulating units (RU), based on a compet-engraftment of nonobese diabetic/severe combined im-
itive repopulation assay (Ema et al., 2000; Harrison etmunodeficiency (NOD/SCID) mice (Peled et al., 1999).
al., 1993; Micklem et al., 1972), in hematopoietic organsHowever, it is uncertain whether the reduction is due to
from control or SDF-1/ embryos. We could measurethe defects in HSCs or more mature progenitors in these
the numbers of RU in SDF-1/ embryos since SDF-transplantation experiments. On the other hand, it has
1/ cells could receive the signal normally from SDF-1been reported that short-term bone marrow engraftment
produced by recipient mice when transferred to lethallyis unaffected by treatment of bone marrow cells with
irradiated wild-type mice (Kawabata et al., 1999). First,pertussis toxin, an inhibitor of signaling by receptors
we examined the numbers of HSCs in fetal liver fromcoupled to heterotrimeric GTP binding proteins includ-
control and SDF-1/ embryos. HSCs are thought toing chemokine receptors (Wiesmann et al., 1999). Thus
move from fetal liver to bone marrow or spleen duringphysiological roles of SDF-1 and CXCR4 in colonization
embryogenesis. HSC activities were found in wild-typeof hematopoietic organs by HSCs remain unclear, de-
fetal liver from E12.5 onward (Figure 2A). Consistent withspite these studies. Here we measured the numbers of
the previous results that erythropoiesis and myelo-HSCs capable of long-term multilineage reconstitution
poiesis in fetal livers were less affected in SDF-1/of adults, in fetal hematopoietic organs from control and
embryos (Nagasawa et al., 1996a; Egawa et al., 2001),SDF-1/ embryos, based on a competitive repopulation
the numbers of HSCs appeared normal in SDF-1/ fetalassay (Ema et al., 2000; Harrison et al., 1993; Micklem
livers from E12.5 to E14.5 (Figure 2A). Subsequently, theet al., 1972). In addition, to determine the functions of
numbers of HSCs in E16.5 SDF-1/ fetal livers wereSDF-1 in the vicinity of endothelial cells, we examined
reduced approximately 2-fold compared with controlthe consequence of enforced expression of SDF-1 in
livers, and the HSC numbers were similar in control andthe endothelial lineage cells in SDF-1/ embryos. We
mutant embryos at E18.5 (Figure 2A). Next, we evaluatedhave shown that the numbers of HSCs as well as myeloid
the numbers of HSCs in bone marrow from control andcells are severely reduced in the bone marrow from SDF-
SDF-1/ embryos. In E18.5 bone marrow, HSCs were1/ embryos and that enforced expression of SDF-1
readily detected in SDF-1/ or SDF-1/ embryos by aunder the control of vascular-specific Tie-2 regulatory
long-term competitive repopulation assay (Figure 2B).
sequences in SDF-1/ embryos completely rescues the
In contrast, HSCs were severely decreased in bone mar-
reduction of HSCs but not myeloid cells in their bone
row from E18.5 SDF-1/ embryos (Figure 2B). Spleen
marrow. Our results suggest that mechanisms by which is also a hematopoietic site throughout life in the mouse.
SDF-1 controls seeding of bone marrow by HSCs and Flow cytometric analysis revealed the reduction in the
myeloid cells are distinct. These findings reveal a critical numbers of myeloid and B lymphocyte lineage cells in
role for SDF-1 in colonization of bone marrow by HSCs E18.5 SDF-1/ spleen compared with control spleen
during ontogeny and provide a molecular basis for ex- while the reductions were less severe than the reduc-
ploring the key components of stem cell niches in bone tions in bone marrow (Figure 1B). Consistent with this,
marrow. the numbers of HSCs were also affected in the E18.5
SDF-1/ spleen, but to a lesser extent than those in
Results bone marrow (Figure 2C).
It has been shown previously that the myeloid cells
Colonization of Bone Marrow by HSCs Is Severely and B cell precursors in peripheral blood were increased
Impaired in SDF-1/ Embryos in CXCR4/ embryos compared with wild-type em-
At later developmental stages, HSCs home to and colo- bryos (Ma et al., 1999). We measured the numbers of
nize the spleen and bone marrow, which is the primary HSCs in fetal peripheral blood from control and SDF-
hematopoietic site throughout adult life. It has been 1/ embryos during embryogenesis. As shown in Figure
shown previously that SDF-1-deficient embryos, which 2D, the numbers of HSCs were greatly increased in the
die at or shortly before birth, reveal the defects in myelo- peripheral blood from E14.5, E16.5, and E18.5 SDF-1/
embryos compared with control embryos (Figure 2D).poiesis and B lymphopoiesis in bone marrow (Nagasawa
HSCs Require SDF-1 for Colonizing Bone Marrow
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Figure 1. Hematopoiesis in E18.5 Bone Mar-
row or Spleen from Control or SDF-1/ Em-
bryos
Flow-cytometric analysis of E18.5 bone mar-
row cells or spleen cells stained with anti-
Ter119, anti-Gr-1, anti-B220, and anti-CD19.
The numbers of Ter119 erythroid cells,
Gr-1 myeloid cells, and B220CD19 B
lymphoid cells were quantified per embryo in
bone marrow (A) or spleen (B).
Since SDF-1 has been shown to be essential for vas- quences of the Tie-2 gene (Tie-2 SDF-1 transgenic mice)
(Schlaeger et al., 1997). Tie-2 is a vascular endothelial-cularization of gastrointestinal tracts (Tachibana et al.,
specific receptor tyrosine kinase and this transcriptional1998), there is the possibility that SDF-1/ embryos
enhancer sequences allow it to target reporter genehave deficits in bone marrow blood vessel formation
expression specifically and uniformly to virtually all vas-that affect hematopoiesis. Then we examined the vascu-
cular endothelial cells throughout embryogenesis andlature in fetal bone marrow from wild-type and SDF-1/
adulthood (Schlaeger et al., 1997). Tie-2 SDF-1 trans-embryos by whole-mount immunohistostains using an
genic mice were healthy and fertile, and crossed withantibody to CD31 (PECAM-1), a marker expressed on
SDF-1/ mice and resultant progeny (Tie-2 SDF-1/SDF-all endothelial cells. There was no significant difference
1/) were backcrossed with SDF-1/ mice. The Tie-2in the vasculature of E18.5 bone marrow between the
SDF-1/SDF-1/ mice were embryonic lethal as werewild-type and SDF-1/ embryos (Figure 3).
SDF-1/ mice. Whole-mount immunohistochemical
analysis of Tie-2 SDF-1/SDF-1/ embryos was per-
Enforced Expression of SDF-1 in Vascular Endothelial formed and revealed the same defects in formation of
Cells Rescues the Colonization of Bone Marrow by the large vessels supplying the gastrointestinal tract as
HSCs but Not by Myeloid Cells in SDF-1/ Embryos those observed in SDF-1/ embryos (data not shown),
Colonization of hematopoietic organs by hematopoietic suggesting that enforced expression of SDF-1 in endo-
cells is thought to occur by multistep processes. Initially, thelial cells did not affect blood vessel formation in the
emigration of hematopoietic cells from the vasculature mutants. Next, we evaluated the numbers of HSCs using
into hematopoietic tissues requires them to roll along RU, based on a competitive repopulation assay in E18.5
the endothelial cells, adhere firmly to endothelial cells, fetal liver, bone marrow, spleen, and peripheral blood
and transmigrate through the endothelium. Thereafter, from litters including SDF-1/, Tie-2 SDF-1/SDF-1/,
hematopoietic cells migrate and adhere to the stem cell SDF-1/, and Tie-2 SDF-1/SDF-1/ embryos. In fetal
niches that support their survival, proliferation, and dif- liver, the numbers of HSCs were similar between SDF-
ferentiation. Thus vascular endothelial cells are thought 1/, Tie-2 SDF-1/SDF-1/, SDF-1/, and Tie-2 SDF-
to be the key elements responsible for the hematopoietic 1/SDF-1/ embryos (Figure 4A). In contrast, there was
colonization events and we speculated that SDF-1 in a significant increase in the numbers of HSCs in bone
the vicinity of the endothelial cells might play a role in marrow from Tie-2 SDF-1/SDF-1/ embryos compared
the colonization of bone marrow by HSCs. To address with SDF-1/ embryos as shown in Figure 4A. These
this possibility, we introduced SDF-1 transgene that was results demonstrated that expression of SDF-1 under
expressed in endothelial cells into SDF-1/ embryos. the control of vascular-specific Tie-2 regulatory se-
Initially, we generated transgenic mice expressing the quences completely rescued the colonization of bone
marrow by HSCs in SDF-1/ embryos. In addition, theSDF-1 gene under the control of the cis-acting se-
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Figure 2. Long-Term Hematopoietic Stem
Cells in Hematopoietic Organs from Control
and SDF-1/ Embryos
The numbers of HSCs were estimated using
repopulating unit (RU), based on a competi-
tive repopulation assay in fetal liver, bone
marrow, spleen, or peripheral blood. Lethally
irradiated Ly5.1 mice were coinjected with
test Ly5.2 cells from hematopoietic organs
and a constant dose of competitor Ly5.1 bone
marrow. At 16 weeks after transplantation,
recipient mice were analyzed for the contribu-
tion to bone marrow cells from test and com-
petitor populations by flow cytometric analy-
sis. The numbers of RU were expressed per
embryo in fetal liver (A), bone marrow (B),
spleen (C), or peripheral blood (D) at different
developmental time points (A and D) or at
E18.5 (B and C).
numbers of HSCs were significantly increased in the in SDF-1/ embryos compared with control embryos
at E18.5 (Figure 2D). However, enforced expression ofspleen from Tie-2 SDF-1/SDF-1/ embryos compared
with SDF-1/ embryos (Figure 4A). As shown above, SDF-1 in endothelial cells did not significantly decrease
the HSC numbers in SDF-1/ peripheral blood (Figurethe numbers of HSCs in peripheral blood were increased
Figure 3. Normal Patterning of Vessels in
Bone Marrow from SDF-1/ Embryos
Whole-mount view of E18.5 wild-type (upper)
and SDF-1/ (lower) bone marrow stained
with an antibody to PECAM-1, a marker ex-
pressed on all endothelial cells. Dashed line,
approximate border of bone marrow cavity.
HSCs Require SDF-1 for Colonizing Bone Marrow
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Figure 4. Enforced Expression of SDF-1 in Endothelial Cells Rescues the Colonization of Bone Marrow by HSCs but Not by Myeloid Cells
(A) Long-term hematopoietic stem cells (HSCs) in E18.5 hematopoietic organs from SDF-1/, Tie-2 SDF-1/SDF-1/, SDF-1/, and Tie-2
SDF-1/SDF-1/ embryos. The numbers of HSCs were estimated using repopulating unit (RU), based on a competitive repopulation assay in
fetal liver, bone marrow, spleen, or peripheral blood. Lethally irradiated Ly 5.1 mice were coinjected with test Ly5.2 cells from hematopoietic
organs and a constant dose of competitor Ly5.1 bone marrow. At 16 weeks after transplantation, recipient mice were analyzed for the
contribution to bone marrow cells from test and competitor populations by flow cytometric analysis. The numbers of RU were expressed per
embryo in fetal liver, bone marrow, spleen, or peripheral blood.
(B) Myelopoiesis in E18.5 bone marrow from SDF-1/, Tie-2 SDF-1/SDF-1/, SDF-1/, and Tie-2 SDF-1/SDF-1/ embryos. Flow-cytometric
analysis of E18.5 fetal liver or bone marrow cells stained with anti-Gr-1. The numbers of Gr-1 myeloid cells were quantified per embryo in
fetal liver and bone marrow.
4A), indicating that accumulation of HSCs in peripheral by HSCs but not by myeloid cells raises the possibility
that myeloid cells in fetal bone marrow are not derivedblood in SDF-1/ embryos was not due to defective
colonization of bone marrow and spleen by HSCs. from HSCs that reside within bone marrow. To address
this issue, we first examined the degree of proliferatingSince SDF-1/ embryos show active myelopoiesis in
fetal liver, the defects observed in myelopoiesis in bone cells in Gr-1 myeloid cells from wild-type fetal liver,
bone marrow, and peripheral blood. In bone marrow,marrow from SDF-1/ mice could not be due to the
defective myelopoiesis but instead due to the defective Gr-1 cells were first detectable at significant levels at
E16.5 and thereafter increased from E16.5 to E18.5 (datacolonization of bone marrow by HSCs. However, surpris-
ingly, flow cytometric analysis revealed that the num- not shown). Sorted Gr-1cells were analyzed by flow
cytometry for DNA content by propidium iodide staining.bers of Gr-1 myeloid cells were significantly reduced
in the bone marrow from E18.5 Tie-2 SDF-1/SDF-1/ The cells in cycle in Gr-1 cells from E18.5 bone marrow
or peripheral blood were almost absent although E18.5embryos compared with Tie-2 SDF-1/SDF-1/ or SDF-
1/ embryos, indicating that defective myelopoiesis in Gr-1 fetal liver cells contained significant numbers of
cells in cycle (Figure 5A). These results indicate that Gr-SDF-1/ fetal bone marrow were not rescued by the
enforced expression of SDF-1 in endothelial cells (Figure 1 cells in bone marrow or peripheral blood are predomi-
nantly nonproliferating although fetal liver contains a4B). Furthermore, enforced expression of SDF-1 under
the control of vascular-specific Tie-2 regulatory se- significant proportion of proliferating Gr-1 cells. Next,
we compared the expression of CXCR4 in Gr-1 myeloidquences did not affect the myelopoiesis in fetal livers
from SDF-1/ embryos (Figure 4B). cells from E18.5 fetal liver, bone marrow, and peripheral
blood by flow cytometry using an anti-mouse CXCR4
mAb. CXCR4 expression in Gr-1 cells from bone mar-Myeloid Cells in Fetal Bone Marrow and Peripheral
Blood Are Predominantly Nonproliferating Relative row was similar to peripheral blood Gr-1cells but signif-
icantly lower compared to fetal liver Gr-1 cells (Figureto Fetal Liver, and Require CXCR4 for Colonizing
Bone Marrow 5B). These data suggest that most of the Gr-1 cells in
fetal bone marrow are not developing within bone mar-The result that expression of SDF-1 under the control
of vascular-specific Tie-2 regulatory sequences in SDF- row but are instead derived from the peripheral circula-
tion. This prompted us to test directly the roles of SDF-11/ embryos rescued the colonization of bone marrow
Immunity
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Figure 5. Gr-1 Myeloid Cells in Fetal Bone
Marrow and Peripheral Blood Were Predomi-
nantly Nonproliferating Relative to Fetal Liver
and Require CXCR4 for Colonizing Bone
Marrow
(A) Cell cycle analysis of Gr-1 cells in E18.5
fetal liver, bone marrow, and peripheral
blood. Cells were stained with anti-Gr-1 and
then 105 cells were sorted, fixed, stained with
propidium iodide, and analyzed by quantita-
tive flow cytometry. The percentage of SG2/
M phase cells is displayed.
(B) Cell surface expression of CXCR4 on Gr-
1 cells in E18.5 fetal liver, bone marrow, and
peripheral blood. Cells were stained with anti-
bodies against CXCR4 and Gr-1 and then an-
alyzed on a flow cytometer. Gr-1 cells in
bone marrow or peripheral blood have lower
levels of CXCR4 in contrast with the Gr-1
cells in fetal liver.
(C) Impaired homing of CXCR4-deficient Gr-
1 cells into bone marrow. Approximately 7
106 (left) or 2  106 (right) calcein-AM-labeled
cells derived from wild-type or CXCR4/ fe-
tal livers were intravenously injected into
wild-type recipients. After 16 hr (left) or 4 hr
(right), cells were isolated from bone marrow
of recipients and analyzed by flow cytometry
using anti-Gr-1 or anti-Ter119, respectively.
The graph shows the donor Gr-1 or Ter119
cells populating bone marrow as a percent-
age of injected Gr-1 or Ter119 cells to com-
pensate for the initial difference in the num-
bers of fetal liver Gr-1 or Ter119 cells,
respectively.
in emigration of the Gr-1 cells into bone marrow. We sels (Peled et al., 1999; Ponomaryov et al., 2000), or
transferred calcein-AM-labeled Gr-1 or Ter119 cells osteoblastic cells (Ponomaryov et al., 2000) in adult or
derived from wild-type or CXCR4/ fetal livers into wild- fetal bone marrow. To study further the localization of
type recipients. Upon sixteen hours of transfer, Gr-1 SDF-1 within fetal bone marrow, two approaches were
cells derived from E18.5 wild-type embryos had mi- utilized. First, we generated the mice in which the GFP
grated to the bone marrow of recipient animals. In con- reporter gene was knocked into the SDF-1 locus (SDF-1/
trast, Gr-1 cells derived from CXCR4/ embryos failed GFP knockin mice). The bone marrow from E18.5 SDF-1/
to colonize recipient bone marrow (Figure 5C). On the GFP embryos were stained with a mAb to the pan-endo-
other hand, E14.5 CXCR4/ Ter119 cells had entered thelial marker PECAM-1 to compare the distribution of
the recipients’ bone marrow with a similar frequency to SDF-1/GFP expressing cells with the distribution of en-
that observed after transfer of wild-type cells (Figure dothelial cells. The blood vessels including medullary
5C). Together, SDF-1 is likely to play an essential role arteries, the network of medullary sinusoids, and venous
in homing of Gr-1 cells into bone marrow from the sinus were observed and SDF-1/GFP expression was
peripheral circulation and enforced expression of SDF-1 seen along the blood vessels in the E18.5 fetal bone
in vascular endothelial cells does not rescue the defec- marrow (Figure 6A). High magnification demonstrated
tive colonization of bone marrow by Gr-1 cells in SDF- that SDF-1/GFP expression was observed in mesenchy-
1/ embryos. mal cells in the vicinity of vascular endothelial cells but
not in the endothelial cells per se (Figure 6B). Next we
performed immunohistostaining using antibodies toSDF-1 Is Located in the Vicinity of the Vascular
Endothelial Cells in Fetal Bone Marrow SDF-1 and PECAM-1. In agreement with the analysis
using SDF-1/GFP knockin mice, SDF-1 was observedIt has been reported that SDF-1 is expressed in spindle-
shaped stromal cells (Nagasawa et al., 1996), microves- in the vicinity of endothelial cells in extravascular spaces
HSCs Require SDF-1 for Colonizing Bone Marrow
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Figure 6. Localization of SDF-1 in Fetal Bone
Marrow
(A and B) Whole-mount view of E18.5 bone
marrow from knockin mice with one GFP
marked SDF-1 allele, showing immunofluo-
rescent staining with an antibody to pan-en-
dothelial signal PECAM-1 (red) and SDF-1/
GFP signal (green) at 10 magnification (A)
and at 40magnification (B). SDF-1-express-
ing cells were seen in the vicinity of endothe-
lial cells in fetal bone marrow.
(C and D) Fluorescence and immunostaining
microscopic analysis of E18.5 bone marrow
sections from wild-type (D) or SDF-1/ (C)
embryos. Sagittal sections of fetal bone mar-
row stained with antibodies to SDF-1 (red)
and PECAM-1 (green). E18.5 SDF-1/ bone
marrow was used as the negative control (C).
Magnification, 40. SDF-1 were detected in
the vicinity of endothelial cells in fetal bone
marrow.
in E18.5 wild-type fetal bone marrow. These findings for the colonization of bone marrow by HSCs from the
peripheral circulation during embryogenesis. Further-are consistent with the notion that SDF-1 adjacent to
more, we revealed that enforced expression of SDF-1endothelial cells plays a critical role in colonization of
in vascular endothelial cells could completely rescuebone marrow by HSCs (Figures 6C and 6D).
the reduction of HSCs in SDF-1/ bone marrow and
spleen. The location and characterization of hematopoi-
Discussion etic stem cell niches remain elusive. Our results suggest
that endothelial cells could function as stromal environ-
In this report, we analyzed the physiological role of ment essential for colonization of fetal bone marrow by
SDF-1 in the colonization of hematopoietic organs by HSCs in the presence of SDF-1. Together with the results
HSCs using a long-term competitive repopulation assay. that demonstrate the location of SDF-1 in the vicinity
HSCs are generated in AGM and expand in fetal liver. of endothelial cells (Figure 6), SDF-1 distributed in the
Then HSCs are released from hematopoietic organs in- mesenchyme surrounding endothelial cells and adja-
cluding fetal liver and colonize bone marrow or spleen cent SDF-1 expressing stromal cells is likely to act as
via the peripheral blood. A long-term competitive repop- a key component of hematopoietic stem cell niches in
ulation assay revealed that, in SDF-1/ embryos, the fetal bone marrow.
numbers of HSCs were comparable in fetal liver and Homing of HSCs into bone marrow is thought to occur
increased in peripheral blood but were severely reduced by different processes including emigration from the
in bone marrow compared to control embryos (Figure vasculature into the stem cell niches through the endo-
thelium, residing, survival, and self-renewing in the2). These results demonstrate that SDF-1 is essential
Immunity
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niches. Considering that SDF-1 is chemotactic for hema- enforced expression of SDF-1 in endothelial cells could
restore the homing of HSCs but not myeloid cells. Intopoietic stem or progenitor cells in vitro (Aiuti et al.,
1997; Hattori et al., 2001; Kim and Broxmeyer, 1998; this case, the cellular and molecular mechanisms of
homing of HSCs and myeloid cells would be different.Peled et al., 1999a; Sweeney et al., 2002), it is possible
that SDF-1 plays a role in extravasation and homing of This hypothesis was called into question by the results
that homing of HSC is severely impaired but erythropoie-HSCs into the stem cell niches. SDF-1 secreted from
stromal cells adjacent to the endothelial cells may arrive sis appears normal in SDF-1/ bone marrow (Figures
1A and 2B). An explanation for this discrepancy is thatin the vessel and regulate adhesion of HSCs to endothe-
lial in bone marrow. In addition, there is also the possibil- absence of SDF-1 does not impair the emigration of
erythroid cells from peripheral blood. Transfer experi-ity that SDF-1 plays a role in promoting survival or self-
renewing of HSCs around endothelial cells in bone ments suggested that CXCR4 was not essential for the
homing of fetal Ter119 erythroid cells from circulationmarrow. Previous studies revealed that SDF-1 sup-
ported the survival or proliferation of hematopoietic pro- into adult bone marrow (Figure 5C). Whichever is the
case, our findings indicate that mechanisms by whichgenitors in vitro (Egawa et al., 2001; Hodohara et al.,
2000; Lataillade et al., 2000, 2002; Nagasawa et al., SDF-1 controls colonization of bone marrow by HSCs
and myeloid cells are different.1994). In this regard, expansion of HSCs in fetal liver
was modestly impaired in SDF-1/ fetal liver from E14.5 HSCs also colonize the spleen as well as bone marrow
at later developmental stages. The reduction in the num-to E16.5 (Figure 2A). On the other hand, in vitro studies
using neutralizing antibodies against SDF-1 revealed a bers of HSCs in SDF-1/ spleen was more modest than
the reduction in SDF-1/ bone marrow although en-role of SDF-1 in autocrine survival of human peripheral
blood CD34CD38 more committed cells (Lataillade forced expression of SDF-1 in endothelial cells rescued
the defects in colonization of spleen by HSCs in SDF-et al., 2002). Since it has been reported that Tie-2 is
expressed on the HSCs (Hsu et al., 2000), there is also 1/ embryos. Therefore it is likely that SDF-1 plays a
role in homing of HSCs to spleen but other cytokinesthe possibility that enforced expression of SDF-1 in
HSCs supports the survival of HSCs through an auto- can substitute in its absence. Thus our results suggest
that molecular mechanisms that control stem cell coloni-crine/paracrine manner and restores the colonization of
bone marrow by HSCs in SDF-1/ embryos. However, zation are different between bone marrow and spleen.
The numbers of HSCs in peripheral blood were in-this possibility is less likely because enforced expres-
sion of SDF-1 did not increase the long-term repopulat- creased in SDF-1/ embryos (Figure 2D). Why are HSCs
accumulated in the peripheral circulation in SDF-1/ing ability for fetal liver cells (Figure 4A).
In contrast to HSCs, enforced expression of SDF-1 embryos? There are several possibilities. First, the num-
bers of HSCs that released from fetal liver, a major reser-in endothelial cells could not rescue the reduction of
myeloid cells in SDF-1/ bone marrow during em- voir for HSCs during embryogenesis, were increased in
SDF-1/ embryos. Second, the numbers of HSCs thatbryogenesis. These results indicate that endothelial
cells cannot function as stromal environment that pro- exited to the peripheral circulation were decreased in
SDF-1/ embryos. This latter possibility is unlikely be-vided appropriate conditions for myeloid development
in fetal bone marrow and suggest that defects in myelo- cause enforced expression of SDF-1 in endothelial cells
restored the migration of HSCs from circulation intopoiesis in SDF-1/ bone marrow are not due simply to
the deficits in colonization by HSCs. Active lymphomy- bone marrow and spleen but did not significantly alter
the accumulation of HSCs in peripheral blood. Furtherelopoiesis appears from E17.5 in bone marrow. First,
HSCs homing to embryonic marrow are thought to give studies will be needed to address this issue.
In contrast with bone marrow or spleen, the numbersrise to hematopoietic precursors and mature blood cells
during ontogeny. In this case, our results suggest that of HSCs in fetal liver were similar in E18.5 SDF-1/,
Tie-2 SDF-1/SDF-1/, SDF-1/, and Tie-2 SDF-1/SDF-myelopoiesis requires the expression of SDF-1 in mes-
enchymal stromal cells in fetal bone marrow. SDF-1 may 1/ embryos (Figure 4A). Thus SDF-1 is dispensable
for development of HSCs in fetal liver. However, sinceattract HSCs or committed precursors to the stromal
cells and/or support their differentiation synergistically the numbers of HSCs in wild-type fetal liver have
reached a maximum at E16.5 but those observed inwith stromal cell-derived molecules. Alternatively, it is
possible that the circulation of lineage committed hema- SDF-1/ fetal liver increased from E16.5 to E18.5 (Figure
2A), there is also the possibility that the expansion oftopoietic progenitors also plays a role in the seeding
of the hematopoietic organs as previously suggested HSCs in fetal liver is impaired or delayed in SDF-1/
embryos. Whichever is the case, it is likely that enforced(Delassus and Cumano, 1996). Since myeloid cells in
bone marrow and peripheral blood were predominantly expression of SDF-1 in endothelial cells could not inhibit
the release of HSCs from fetal liver or recruit HSCs fromnonproliferating relative to fetal liver and since levels of
cell surface expression of CXCR4 in myeloid cells in the peripheral circulation into fetal liver.
Chemokines have been shown to activate integrinbone marrow were similar to peripheral blood but low
compared to fetal liver (Figures 5A and 5B), we hypothe- functions in hematopoietic cells (Tanaka et al., 1993).
Colonization of hematopoietic organs has been shownsize that the majority of hematopoietic cells in fetal bone
marrow are derived from the peripheral circulation. to require 1 integrins (Hirsch et al., 1996; Potocnik et
al., 2000). However, there were phenotypic differencesTransfer experiments revealed that myeloid cells de-
rived from CXCR4/ fetal liver failed to colonize adult between mutants lacking SDF-1 and 1 integrins. While
1 integrin-deficient hematopoietic cells were unable tobone marrow (Figure 5C). Thus, SDF-1 would play a
critical role in recruiting myeloid cells as well as HSCs seed fetal liver, development of HSCs, erythroid, and
myeloid cells were less affected in SDF-1/ fetal livers.from the peripheral circulation into bone marrow and
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cells were pelleted, resuspended in phosphate-buffered saline (PBS)How SDF-1 regulates the functions of integrins in coloni-
containing 2% FCS, and analyzed with FACSCalibur (Becton Dickin-zation of bone marrow by HSCs is an important question
son) or sorted with FACSVantageSE (Becton Dickinson). Dead cellsfor the future.
were excluded by propidium iodide (PI) staining.
It had been thought that colonization of bone marrow
by HSCs occurred only during embryogenesis or in Competitive Repopulation Assay
pathological cases where there was more demand for The numbers of HSCs were estimated using repopulating unit (RU),
based on a competitive repopulation assay (Ema et al., 2000; Har-hematopoiesis. However, it has been shown that HSCs
rison et al., 1993; Micklem et al., 1972). As Ly5.2 test cells, we usedconstitutively migrate through the blood and play a
fetal liver cells (from E12.5 to E18.5), bone marrow cells, spleenphysiological role in the functional reengraftment of un-
cells, and peripheral blood cells. 1  106 fetal liver cells (from E13.5conditioned adult bone marrow (Wright et al., 2001).
to E18.5) were mixed with 2  106 cells of competitor Ly5.1 bone
Thus it will be interesting to clarify the role of SDF-1 marrow. 1  106 (E12.5) fetal liver cells, a third of bone marrow cells
in the physiological migration of HSCs throughout and peripheral blood cells, and half of spleen cells were mixed with
1  106 cells of competitor Ly5.1 bone marrow. A cell mixture in 0.3adult life.
ml of D-MEM was injected intravenously into a group of recipientTogether, the data presented here reveal that SDF-1
C57BL/6-Ly5.1 mice lethally irradiated at a single dose of 1,100is essential for colonization of bone marrow by HSCs
rads. At 16 weeks after transplantation, recipient mice were analyzedduring ontogeny and define SDF-1 as a key component
for the contribution to bone marrow cells from test and competitor
of hematopoietic stem cell niches. This study has pro- populations by flow cytometric analysis. Percentage of donor-type
vided an invaluable window into the molecular basis of in bone marrow myeloid cells, which are short-lived, were correlated
to those in bone marrow B cell precursors and thus are a goodhematopoietic colonization events by stem cells.
indication for relative hematopoietic stem cell activity. RU was cal-
culated using Harrison’s method (Ema et al., 2000; Harrison et al.,Experimental Procedures
1993; Micklem et al., 1972). If a test population contains 1 RU, it
populates as well as 105 fresh competitor bone marrow cells.Mice
The generation of SDF-1/ and CXCR4/ mice has been described
previously (Nagasawa et al., 1996a; Tachibana et al., 1998). SDF- Immunohistochemical Staining and Confocal Microscopy
For section staining, samples were fixed in 4% paraformaldehyde,1/ and CXCR4/ mice were backcrossed more than ten times
with C57BL/6-Ly5.2 mice. C57BL/6-Ly5.1 mice were a gift from Drs. equilibrated in 30% sucrose/PBS, and frozen. Then, sections were
incubated with rat anti-PECAM-1 antibody (MEC13.3, BD Phar-M. Osawa and H. Nakauchi (University of Tokyo, Tokyo, Japan).
Mingen), rabbit anti-SDF-1 antibody (Torroy Pines Biolabs),
Alexa488-conjugated goat anti-rat IgG (Molecular Probe, Eugene,Generation of Transgenic Mice
OR), biotinylated-anti-rabbit IgG (Jackson ImmunoResearch Labo-Tie2 kinase promoter/enhancer (Schlaeger et al., 1997), released
ratories, West Grove, PA), and Alexa546-conjugated streptavidinfrom pSPTg.T2FXK (a gift from T.N. Sato, The University of Texas,
(Molecular Probe).Dallas, Texas), rabbit -globin intron, mouse polyadenylation signal
For whole-mount immunohistochemistry, fetal bones from SDF-1/sequences were introduced into pBlu-SDF-1/PBSF that contains
GFP knockin mice were fixed in 4% paraformaldehyde, permeabil-murine SDF-1 cDNA. DNA was linealized and used for pronuclear
ized with PBS containing 0.3% Triton X-100 (PBST), and blockedmicroinjection to obtain Tie2 SDF-1 transgenic mice.
with PBST containing 1% skim milk (DIFCO). Then, tissues were
stained with rat anti-PECAM-1 antibody and Alexa546-conjugatedGeneration of GFP Knockin Mice
goat anti-rat IgG (Molecular Probe).To obtain SDF-1 directed GFP expression, exon 2 of the SDF-1
Tissues were mounted with Slowfade Antifade kit (Moleculargene was replaced by GFP expression cassette by homologous
Probe). All confocal microscopy was carried out on a LSM 5 PASCALrecombination in ES cells (Nagasawa et al., 1996). Mutated ES colo-
(Carl Zeiss).nies were used to produce mice hemizygous for the GFP insertion
by blastocyst injection as described (Nagasawa et al., 1996a). Mice
Cell Cycle Analysishemizygous for the GFP insertion that have one functional SDF-1
Cell suspension incubated on ice for 30 min with FITC-conjugatedallele are phenotypically normal and can be used for the analysis
anti-Gr-1 were washed with D-MEM containing 2% FCS and 0.01%of SDF-1 expression.
NaN3 before sorting in a FACSVantage SE. For cell cycle analysis,
cells suspended in ice-cold ethanol overnight were pelleted by cen-Cell Preparation
trifugation and treated with RNase A (Sigma) for 30 min at 37CFetal liver, bones, and spleen were isolated under a dissecting mi-
before incubation in the dark on ice for 30 min in a solution containingcroscope (Leica). Fetal liver cells were suspended in D-MEM con-
PI at 50 g/ml. The PI fluorescence of individual nuclei was mea-taining 2% fetal calf serum (FCS) through needles of 18- to 21-
sured using FACSCalibur, and cell cycle analysis was performedgauge. Fetal bone marrow cells were harvested from both sides of
with ModFit LT software (Becton Dickinson).scapula, humerus, ulna, radius, femur, fibula, and tibia. Fetal bones
and spleen were crushed between glass slides and resuspended in
Cell Homing AssayD-MEM containing 2% FCS. Fetal peripheral blood was collected
Cells isolated from fetal liver were labeled for 5 min at 37C with 3by decapitating the embryo in D-MEM containing 2% FCS. Adult
M Calcein-AM (Dojindo, Kumamoto, Japan). Washed cells werebone marrow cells from femurs were suspended in D-MEM con-
injected into the tail vein of 6- to 8-week-old mice. 16 (Gr-1 cells)taining 2% FCS by repeated flushing through a 21-gauge needle.
or 4 (Ter119 cells) hr later, they were sacrificed, and cells isolatedCell suspensions were filtered through nylon mesh to remove debris.
from bone marrow were stained with biotinylated anti-Gr-1 or anti-
Ter119 antibody, followed by APC-conjugated streptavidin, and an-Staining, Flow Cytometry Analysis, and Cell Sorting
alyzed by flow cytometry. Based on the bright green fluorescenceAntibodies used in this study were as follows: FITC-conjugated anti-
of Calcein labeling and APC labeling of the antibody, the numbersLy5.2 (clone: 104), anti-Ter119, anti-Gr-1 (RB6-8C5), and anti-B220
of transferred myeloid or erythroid cells were expressed as the(RA3-6B2); PE-conjugated anti-Gr-1 (RB6-8C5) and anti-CD19 (1D3);
amount of double positive cells.biotinylated anti-CXCR4 (2B11), anti-Gr-1 (RB6-8C5) and isotype
control IgG2b (A95-1). All antibodies were purchased from BD
PharMingen (San Diego, CA). Acknowledgments
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